Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06042127 · ClinicalTrials.gov registry record · NA
POEM-F for Achalasia International Study
A NA study of Achalasia, sponsored by Chinese University of Hong Kong.
- Recruiting
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 7
- Study locations
NCT06042127: Recruiting NA study of Achalasia, sponsored by Chinese University of Hong Kong.
NCT06042127 is a NA study of Achalasia that is actively recruiting participants, run by Chinese University of Hong Kong. The registered enrollment target is 81 participants, below the 130-participant average among 7 other Achalasia trials with a reported enrollment target (38% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06042127, a NA study of Achalasia, is actively recruiting participants, sponsored by Chinese University of Hong Kong.
- RECRUITING
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 7
- Study locations
Study Summary
Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been developed as a novel procedure mimicking surgical anterior partial fundoplication that can be performed in the same session as POEM (POEM-F). Case series of POEM-F in patients with achalasia reported encouraging outcomes of low GERD rate of \~12% at 1 year. Prospective comparative data between POEM-F and conventional POEM on post-procedure GERD is current lacking. The investigators therefore designed an international multicenter prospective randomized study to investigate the efficacy of POEM-F. The investigators postulate that POEM-F could reduce the incidence of post-procedure GERD when compared with conventional POEM. This is an international multicenter randomized controlled trial conducted between high volume expert centers from Hong Kong SAR, China, India and United States of America. Adult patients with manometry confirmed achalasia would be randomised to undergo POEM-F or POEM. The procedure would be performed by experts with vast experience in POEM. The primary outcome is the incidence of post-procedure GERD at 1 year, defined by the updated Lyon consensus. Secondary outcomes include technical and clinical success rates, adverse events, post-POEM endoscopic and manometry findings as well as patients' symptom scores. Sample size calculation Based on existing pilot comparative data on POEM-F and POEM, it is estimated that 84 patients would be required to demonstrate a difference in post-procedure GERD of 47.6% to 18.2%, with 80% power and false positive rate of 0.05, accounting for 10% loss to follow-up. Purpose and potential The current study proposal could demonstr
Primary Outcome
Defined by updated Lyon 2.0 consensus as fulfilling one or more of the criteria: 1. Endoscopic erosive esophagitis, LA grade B or above 2. Long segment Barrett's esophagus 3. Peptic esophageal stricture 4. 24-hour pH study with acid exposure time \>6% Both endoscopy and pH study to be performed with proton pump inhibitor stopped for 4 weeks
Conditions Studied
Interventions
- PROCEDURE POEM-F
- PROCEDURE Conventional POEM
Study Locations (7)
Other
- Nanfang Hospital, Southern Medical University - Guangzhou
- The Chinese University of Hong Kong - Hong Kong
- Post Graduate Institute of Medical Education and Research - Chandigarh
- Asian Institute of Gastroenterology - Hyderabad
- Baldota Institute of Digestive Sciences - Mumbai
- Deenanath Mangeshkar Hospital & Research Center - Pune
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT06042127 shows while recruiting
NCT06042127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 130-participant average among 7 other Achalasia trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Achalasia appearing as the primary indexed condition, and to 2 interventions - of which POEM-F is the first listed.
NCT06042127 lists 7 locations in 2 states (Other, Maryland).
Frequently Asked Questions
What is clinical trial NCT06042127 about?
NCT06042127 is a clinical study titled "POEM-F for Achalasia International Study". Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in u...
What is the current status of trial NCT06042127?
This trial is currently recruiting. It is a NA study. The enrollment target is 81 participants. The study started on 2023-12-01. Estimated completion is 2026-10-31.
What conditions does trial NCT06042127 study?
This clinical trial studies the following conditions: Achalasia.
What interventions are being tested in trial NCT06042127?
The interventions under investigation include: POEM-F (PROCEDURE), Conventional POEM (PROCEDURE).
Who is sponsoring clinical trial NCT06042127?
This trial is sponsored by Chinese University of Hong Kong, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06042127 being conducted?
This trial has 7 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achalasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility
COMPLETED · NA
-
Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia
COMPLETED · NA
-
Short Vs Standard Length Myotomy in Achalasia
COMPLETED · NA
-
Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
RECRUITING
-
VZV in the Enteric Nervous System: Pathogenesis and Consequences
RECRUITING · Phase 4
-
Comprehensive Esophageal Diagnostics Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI